Becoming data-centric: A conversation with global R&D leaders
Leading biopharma companies are universally undertaking digital transformation efforts to stay ahead of scientific and business opportunities. Becoming data-centric is essential to operate as a nimble, fast-moving, highly-connected, and information-centered R&D organization.
In this conversation, two global biotech leaders share how their organizations evolved how their R&D teams work. They share how the transformation process is easier — and more impactful — than expected.
Head of Genome Technology and Computational Sciences at Biogen
Head of Enterprise Professional Services at Benchling